Back
Compare AU
Compare IHD vs. HLTH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares S&P/ASX Div Opportunities Esg Screened ETF (IHD) and the VanEck Global Healthcare Leaders ETF (HLTH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IHD | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 85 | 54 |
Median incremental investment | $807.95 | $550.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,562.28 | $1,531.53 |
Average age group | > 35 | > 35 |
Key Summary
IHD | HLTH | |
|---|---|---|
Strategy | IHD.AX was created on 2010-12-06 by iShares. The fund's investment portfolio concentrates primarily on high dividend yield equity. The ETF currently has 388.84m in AUM and 50 holdings. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of 50 ASX listed stocks that offer high dividend yields while meeting diversification, profitability and tradability requirements as well as being screened for sustainability considerations | HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars. |
Top 3 holdings | WESTPAC BANKING CORPORATION CORP (10.34 %) NATIONAL AUSTRALIA BANK LTD (9.88 %) ANZ GROUP HOLDINGS LTD (9.84 %) | Globus Medical Inc Class A (2.86 %) Swedish Orphan Biovitrum AB (2.69 %) Merck & Co Inc (2.64 %) |
Top 3 industries | Financials (44.69 %) Materials (25.27 %) Industrials (15.28 %) | Health Care (100.00 %) Other (9.10 %) |
Top 3 countries | Australia (99.86 %) New Zealand (0.14 %) | United States (65.74 %) Japan (10.95 %) Denmark (8.04 %) |
Management fee | 0.23 % | 0.45 % |
Key Summary
IHD | HLTH | |
|---|---|---|
Issuer | iShares | VanEck |
Tracking index | S&P/ASX Dividend Opportunities Index - AUD | MarketGrader Developed Markets ex-Australia Health Care Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.23 % | 0.45 % |
Price | $16.62 | $11.22 |
Size | $375.943 million | $50.690 million |
10Y return | 28.04 % | N/A |
Annual distribution yield (5Y) | 5.45 % | 0.61 % |
Market | ASX | ASX |
First listed date | 09/12/2010 | 09/09/2020 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IHD | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 85 | 54 |
Median incremental investment | $807.95 | $550.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,562.28 | $1,531.53 |
Average age group | > 35 | > 35 |
Pros and Cons
IHD | HLTH | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IHD | HLTH |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |